Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Cohn

Showing results (291-300 of 302) with videos related to

Pageof 31
Sort By:
Gynecologic Oncology|May 6, 2023
The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary studyTiffany Y Sia, William P Tew, Christopher Purdy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2015
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group StudyPaul J Goodfellow, Caroline C Billingsley, Heather A Lankes, et al.
Cancer Causes & Control : CCC|August 23, 2019
Inherited alterations of TGF beta signaling components in Appalachian cervical cancersThomas J Knobloch, Juan Peng, Erinn M Hade, et al.
European Radiology Experimental|December 6, 2023
Deep learning-based segmentation of multisite disease in ovarian cancerThomas Buddenkotte, Leonardo Rundo, Ramona Woitek, et al.
The New England Journal of Medicine|November 14, 2019
Secondary Surgical Cytoreduction for Recurrent Ovarian CancerRobert L Coleman, Nick M Spirtos, Danielle Enserro, et al.
Gynecologic Oncology Reports|July 7, 2023
Assessment of the feasibility of same-day discharge following minimally invasive hysterectomy in the elderly populationPaulina J Haight, Rachael N Piver, David A Barrington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial)Husam A Alqaisi, David E Cohn, Jing-Yi Chern, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 7, 2011
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal statusSteven J Skates, Phuong Mai, Nora K Horick, et al.
Genes & Development|August 26, 2015
Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivoEnrico Caserta, Onur Egriboz, Hui Wang, et al.
Gynecologic Oncology|March 19, 2023
Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysisTheodore M Brasky, Erinn M Hade, David E Cohn, et al.
Pageof 31

Showing results (291-300 of 302) with videos related to

Sort By:
Pageof 31
Gynecologic Oncology|May 6, 2023
The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary studyTiffany Y Sia, William P Tew, Christopher Purdy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2015
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group StudyPaul J Goodfellow, Caroline C Billingsley, Heather A Lankes, et al.
Cancer Causes & Control : CCC|August 23, 2019
Inherited alterations of TGF beta signaling components in Appalachian cervical cancersThomas J Knobloch, Juan Peng, Erinn M Hade, et al.
European Radiology Experimental|December 6, 2023
Deep learning-based segmentation of multisite disease in ovarian cancerThomas Buddenkotte, Leonardo Rundo, Ramona Woitek, et al.
The New England Journal of Medicine|November 14, 2019
Secondary Surgical Cytoreduction for Recurrent Ovarian CancerRobert L Coleman, Nick M Spirtos, Danielle Enserro, et al.
Gynecologic Oncology Reports|July 7, 2023
Assessment of the feasibility of same-day discharge following minimally invasive hysterectomy in the elderly populationPaulina J Haight, Rachael N Piver, David A Barrington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial)Husam A Alqaisi, David E Cohn, Jing-Yi Chern, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 7, 2011
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal statusSteven J Skates, Phuong Mai, Nora K Horick, et al.
Genes & Development|August 26, 2015
Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivoEnrico Caserta, Onur Egriboz, Hui Wang, et al.
Gynecologic Oncology|March 19, 2023
Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysisTheodore M Brasky, Erinn M Hade, David E Cohn, et al.
Pageof 31